Type 1 diabetes mellitus (T1DM) is a complex, heterogeneous disease mediated by the interaction of genetic and non-genetic factors.
Autoimmune diabetes in adults is as prevalent as childhood-onset T1DM, but the clinical phenotype ranges from insulin-dependent to non-insulin dependent. This latter phenotype resembles type 2 diabetes and has been called latent autoimmune diabetes of adults (LADA), or, in the Japanese, slowly progressive insulin dependent diabetes (SPIDDM). Intriguingly, in adult-onset autoimmune diabetes, irrespective of its mode of presentation, the protective HLA DQB1*0602 genotype is as prevalent as in controls, while it is rare in childhood-onset T1DM. In other words, the HLA-mediated dominant protection typical of childhood-onset T1DM is lost in adult-onset autoimmune diabetes. The likely role of antigen-specific T regulatory cells for this HLAmediated dominant protection provides clear inference that an aggressive adaptive immune response is less vital in adult-onset disease (Ooi et al., 2017) .
The study of Japanese adult-onset diabetes cases (Mine et al., 2017) implicates some role for viruses, supported by the increased frequency of mild respiratory infections before diagnosis. Furthermore, given that respiratory viral infections and variants of the IFIH1 gene (interferon induced with helicase C domain 1) predispose to childhood-onset T1DM (Gorman et al., 2017) , it follows that viral infections may contribute to T1DM across a wide age-range.
In line with a key role for viruses, the Japanese investigators had previously shown that partial loss-of-function of TYK2 was responsible for making mice susceptible to virus-induced diabetes, perhaps due to inadequate IFN responses. Shortly thereafter, they also associated TYK2 promoter variants with human diabetes. It is possible, therefore, that the TYK2 variant enriched in the subgroup of insulin-dependent Japanese patients could increase susceptibility to infection and, consequently, to diabetes (Mine et al., 2017; Kreins et al., 2015) .
TYK2-dependent IFNL isoforms and their receptor are specifically expressed in epithelial cells, including pancreatic islet cells (Lind et al., 2013) . Stimulation of cultured human islets by exogenous IFNL activates the JAK1 and TYK2 kinases which drive the expression of interferoninducible genes. In coxsackievirus B3-infected islets it has been shown that IFNL up-regulates anti-viral defences and restrains both virus replication and cytopathic effects (Lind et al., 2013) .
Taken together, the new findings imply that individuals carrying TYK2 variants may be a target of slowly-acting pancreotropic viruses due to their dampened IFN response (Genoni et al., 2017; Mine et al., 2017) . The results could also be of therapeutic value, as inhibitors of JAK kinases (including TYK2) are potentially valuable in autoimmune (Roskoski, 2016) , in which we would aim for protection from autoimmunity without inducing immunodeficiency.
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In virus-induced diabetes, however, treatment should primarily aim at blocking the virus that may be replicating into endocrine cells. At present, IFNL is being tested for chronic B and C hepatitis. Promising results have been obtained by administering pegylated IFNL that generates a robust innate and adaptive immunity and also co-operates in virus clearance (Phillips et al., 2017) .
Thus, TYK2 deficiency, if confirmed as relevant to some cases of insulin-dependent diabetes, might reflect a treatable single-gene inborn error of immunity that predisposes to diabetes (Kreins et al., 2015) . Identification of such genetically susceptible subjects and the development of appropriate antiviral vaccines could reduce the risk of virusinduced diabetes.
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